Fingolimod News and Research

RSS
Therapeutic inertia in the treatment of women with multiple sclerosis revealed

Therapeutic inertia in the treatment of women with multiple sclerosis revealed

Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes

Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Novel and emerging therapies offer new hope for patients with inflammatory bowel disease

Insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis

Insights into the pathophysiological mechanisms governing neuropsychiatric symptoms of multiple sclerosis

Research reveals a more effective treatment for multiple sclerosis patients

Research reveals a more effective treatment for multiple sclerosis patients

What is the potential role of sphingosine kinase inhibitors as antiviral agents?

What is the potential role of sphingosine kinase inhibitors as antiviral agents?

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

Induction and stability of vaccine-specific antibodies in multiple sclerosis patients on different disease-modifying therapies

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

Fighting SARS-CoV-2 with nanomedicine

Fighting SARS-CoV-2 with nanomedicine

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Insufficient evidence for cognitive efficacy of drug treatments in multiple sclerosis

Schizophrenia related to abnormal fatty metabolism in the brain

Schizophrenia related to abnormal fatty metabolism in the brain

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers develop fast diagnostic tool that shows MS patients in relapse

Researchers use structural biology techniques to understand how lipids bind proteins

Researchers use structural biology techniques to understand how lipids bind proteins

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

Targeting biochemical pathway may lead to new therapies for alleviating symptoms of anxiety disorders

UA pharmacology professors aim to avoid opioid analgesic tolerance

UA pharmacology professors aim to avoid opioid analgesic tolerance

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

FDA and EMA accept Novartis' regulatory application for siponimod to treat SPMS in adults

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.